Aspiriant, LLC Dexcom Inc Transaction History

Aspiriant, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$76.35 - $94.18 $152 - $188	2 Added 0.03%	7,226 $581,000
Q2 2022 Jul 25, 2022	BUY	$67.99 - $132.89 $369,729 - $722,655	5,438 Added 304.48%	7,224 $539,000
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $3,669 - $5,077	-39 Reduced 2.14%	1,786 $913,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $237,012 - $297,146	1,825 New	1,825 $980,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.